<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01238731</url>
  </required_header>
  <id_info>
    <org_study_id>UKB_001_2010</org_study_id>
    <nct_id>NCT01238731</nct_id>
  </id_info>
  <brief_title>Persistent Pulmonary Artery Hypertension After Valve Replacement</brief_title>
  <acronym>SALT</acronym>
  <official_title>Persistence of Severe Pulmonary Artery Hypertension in Patients After vaLve replacemenT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Actelion Pharmaceuticals Deutschland GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Persistent severe pulmonary hypertension (PH) after mechanical valve replacement
      is a frequent finding in patients with severe valve-diseases. The reasons to develop PH are
      multifactorial and the prevalence of severe PH significantly worsens the patientsÂ´ outcome.

      Aims: (i) To define the prevalence of PH in patients after valve replacement and (ii) to
      identify factors predicting persistent PH.

      Methods: All patients which underwent valve replacement at our institution between the years
      2008 -2010 will be screened retrospectively. Those patients with pre- procedural proven PH by
      means of right-heart catheterization will receive prospective follow-up with
      echocardiography. Diagnosis of persistent PH will be confirmed with right heart
      catheterization.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Persistence of pulmonary hypertension after valve replacement for treatment of severe valve disease</measure>
    <time_frame>&gt; 6 months after valve therapy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACCE, all cause mortality during FU</measure>
    <time_frame>Within 24 months after valve therapy</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Persistent Severe PH After Valve Therapy</condition>
  <arm_group>
    <arm_group_label>Valve replacement</arm_group_label>
    <description>Patients undergoing valve replacement for severe valve disease will be screened for study entry</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with proven PH before valve replacement by right heart catherterization will be
        screened for study entry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Proven pulmonary hypertension before valve replacement and informed consent for data
             acquisition

        Exclusion Criteria:

          -  patients do not meet inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christoph Hammerstingl, MD</last_name>
    <phone>+4922815951</phone>
    <email>christoph.hammerstingl@ukb.uni-bonn.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dirk Skowasch, MD, PhD</last_name>
    <phone>+4922816076</phone>
    <email>dirk.skowasch@ukb.uni-bonn.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medizinische Klinik II, University of Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Schueler, MD</last_name>
      <phone>+4922815507</phone>
      <email>robert.schueler@ukb.uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Pabst, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2010</study_first_submitted>
  <study_first_submitted_qc>November 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2010</study_first_posted>
  <last_update_submitted>November 10, 2010</last_update_submitted>
  <last_update_submitted_qc>November 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Christoph Hammerstingl</name_title>
    <organization>Universitiy of Bonn, Medizinische Klinik und Poliklinik II</organization>
  </responsible_party>
  <keyword>Valve replacement</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>long term follow up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

